NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/12/2023
Back to search
Official data from USPTO
BOTOX ONE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BOTOX ONE
ST13
US500000097115552Class
35, 44
Filing
97115552
Registration
7243677
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
01/13/2024
Trademark type
Word
Nice classes
35, 44
Filing date
11/09/2021
Registration date
12/12/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/12/2023
Last transaction
01/13/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/19/2019
First use in commerce
01/19/2019
Drawing code
4
Owner type
03
Owner location
North Chicago, IL, US
Examiner
DONEGAN, DANIEL
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Allergan, Inc.
Allergan, Inc.
Representatives
Allergan, Inc.
Technical classification
Nice Classes
Class 35Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting healthcare professionals' awareness of the benefits of botulinum toxin and dissemination of advertisements and consumer product information relating to botulinum toxin via printaudiovideodigitalon-line mediumelectronic mail; Providing business information about the administration of patient reimbursement programs designed to assist patients regarding medical treatment payment plan options; assistance to patients regarding treatment payment plan optionsbusiness administration of patient reimbursement programs; providing a website via a global computer network featuring consumer information and comprehensive content being consumer product information in the fields of neurologydermatology and urology; distribution of samples for trial purposes in the field of neurologydermatology and urology
Class 44
Providing resources in the nature of health information for healthcare professionals relating to all approved indications of therapeutic treatments and injection instruction in the fields of neurology and urology
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/12/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/09/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/08/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
11/08/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/08/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
11/08/2023
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
11/08/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/01/2023
GNRT
NON-FINAL ACTION E-MAILED
11/01/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
11/01/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/16/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/10/2023
IUAF
USE AMENDMENT FILED
04/21/2023
EISU
TEAS STATEMENT OF USE RECEIVED
04/21/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/29/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/04/2022
PUBO
PUBLISHED FOR OPPOSITION
10/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/14/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/30/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/29/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/29/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/07/2022
GNFR
FINAL REFUSAL E-MAILED
06/07/2022
CNFR
FINAL REFUSAL WRITTEN
06/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/16/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/16/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/16/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/29/2021
GNRT
NON-FINAL ACTION E-MAILED
11/29/2021
CNRT
NON-FINAL ACTION WRITTEN
11/29/2021
DOCK
ASSIGNED TO EXAMINER
11/24/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/18/2021
Continuous trademark protection
Get notified about every new filing that threatens BOTOX ONE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.